Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Pietzak
Dr. Eugene Pietzak is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 7 years. He is one of 85 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 70 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2015 - 2017
University of Pennsylvania Health SystemResidency, Urology, 2011 - 2015
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 2010 - 2011
Stony Brook University Health Sciences Center School of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2015 - 2026
NJ State Medical License 2021 - 2025
PA State Medical License 2010 - 2015
American Board of Urology Urology
Clinical Trials
- Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment Start of enrollment: 2019 Nov 22
- A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer Start of enrollment: 2022 Feb 17
Roles: Principal Investigator, Contact
- Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)] Start of enrollment: 2018 Jun 27
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.Rayan Rammal, Florestan J Koll, Ziyu Chen, Jacob E Tallman, Syed Muneeb Alam
Modern Pathology. 2025-06-17 - Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity.Andrew W Daman, Anthony C Antonelli, Gil Redelman-Sidi, Lucinda Paddock, Shireen Khayat
Cancer Cell. 2025-05-28 - Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer.Manuel R De Jesus Escano, Emily A Vertosick, Neeta D'Souza, Nicole Benfante, Andrew T Lenis
Urologic Oncology. 2025-05-24
Press Mentions
Breakthrough Discoveries in Bladder Cancer Treatment Pave the Way for Enhanced ImmunotherapiesMay 29th, 2025- BCG Immunotherapy Reprograms Bone Marrow to Boost Cancer DefenseMay 28th, 2025
- New Insights into Decades-Old Bladder Cancer Treatment Offers Clues for ImmunotherapyMay 28th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
